| 2024 | | Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 | 이문재 |
| 2022 | | Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 A Systematic Analysis for the Global Burden of Disease Study 2019 | 이요한 |
| 2024 | | Evaluating the Frequency of Mole Checks by a Dermatologist and Correlated Variables in a Global Survey across 17 Countries: HELIOS Project | 강희영 |
| 2024 | | Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021 | 이문재 |
| 2024 | | Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 | 이문재 |
| 2024 | | Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 | 이문재 |
| 2024 | | Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 | 이문재 |
| 2023 | | Global Burden of Cardiovascular Diseases and Risks, 1990-2022 | 이문재 |
| 2014 | | Global estimates of the prevalence of hyperglycaemia in pregnancy. | 조남한 |
| 2024 | | Global estimates on the number of people blind or visually impaired by age-related macular degeneration: a meta-analysis from 2000 to 2020 | 이문재 |
| 2024 | | Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020 | 이문재 |
| 2024 | | Global estimates on the number of people blind or visually impaired by Uncorrected Refractive Error: a meta-analysis from 2000 to 2020 | 이문재 |
| 2024 | | Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 | 이문재 |
| 2021 | | Global impact of COVID-19 on stroke care | 이진수, 홍지만 |
| 2024 | | Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 | 이문재 |
| 2023 | | Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 | 이문재 |
| 2024 | | Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 | 이문재 |
| 2017 | | IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040 | 조남한 |
| 2018 | | IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045 | 조남한 |
| 2022 | | Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020 | 이윤환 |
| 2021 | | Spatial, temporal, and demographic patterns in prevalence of chewing tobacco use in 204 countries and territories, 1990-2019: A systematic analysis from the Global Burden of Disease Study 2019 | 이요한 |
| 2022 | | The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019 | 이윤환 |
| 2014 | | The impact of age on fractional flow reserve-guided percutaneous coronary intervention: a FAME (Fractional Flow Reserve versus Angiography for Multivessel Evaluation) trial substudy. | 임홍석 |
| 2021 | | Trends in the incidence of diagnosed diabetes: a multicountry analysis of aggregate data from 22 million diagnoses in high-income and middle-income settings | 김대중, 하경화 |
| 2019 | | Validation of a physician global assessment tool for vitiligo extent: Results of an international vitiligo expert meeting | 강희영 |
